These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 17870532

  • 1. Novel heparin/heparan sulfate mimics as inhibitors of HGF/SF-induced MET activation.
    Raiber EA, Wilkinson JA, Manetti F, Botta M, Deakin J, Gallagher J, Lyon M, Ducki SW.
    Bioorg Med Chem Lett; 2007 Nov 15; 17(22):6321-5. PubMed ID: 17870532
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enhanced growth of human met-expressing xenografts in a new strain of immunocompromised mice transgenic for human hepatocyte growth factor/scatter factor.
    Zhang YW, Su Y, Lanning N, Gustafson M, Shinomiya N, Zhao P, Cao B, Tsarfaty G, Wang LM, Hay R, Vande Woude GF.
    Oncogene; 2005 Jan 06; 24(1):101-6. PubMed ID: 15531925
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP, Hose CD, Koochekpour S, Jeffers M, Oskarsson M, Sausville E, Monks A, Vande Woude GF.
    Cancer Res; 2000 Jan 15; 60(2):342-9. PubMed ID: 10667586
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
    Pasdar M, Li Z, Marreli M, Nguyen BT, Park M, Wong K.
    Cell Growth Differ; 1997 Apr 15; 8(4):451-62. PubMed ID: 9101091
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
    Weidner KM, Hartmann G, Naldini L, Comoglio PM, Sachs M, Fonatsch C, Rieder H, Birchmeier W.
    EXS; 1993 Apr 15; 65():311-28. PubMed ID: 8380739
    [Abstract] [Full Text] [Related]

  • 11. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).
    Hendrix MJ, Seftor EA, Seftor RE, Kirschmann DA, Gardner LM, Boldt HC, Meyer M, Pe'er J, Folberg R.
    Am J Pathol; 1998 Apr 15; 152(4):855-63. PubMed ID: 9546344
    [Abstract] [Full Text] [Related]

  • 12. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP).
    Donate LE, Gherardi E, Srinivasan N, Sowdhamini R, Aparicio S, Blundell TL.
    Protein Sci; 1994 Dec 15; 3(12):2378-94. PubMed ID: 7756992
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mimp, a mitochondrial carrier homologue, inhibits Met-HGF/SF-induced scattering and tumorigenicity by altering Met-HGF/SF signaling pathways.
    Leibowitz-Amit R, Tsarfaty G, Abargil Y, Yerushalmi GM, Horev J, Tsarfaty I.
    Cancer Res; 2006 Sep 01; 66(17):8687-97. PubMed ID: 16951184
    [Abstract] [Full Text] [Related]

  • 15. Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling.
    Sakata H, Stahl SJ, Taylor WG, Rosenberg JM, Sakaguchi K, Wingfield PT, Rubin JS.
    J Biol Chem; 1997 Apr 04; 272(14):9457-63. PubMed ID: 9083085
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.
    Jeffers M, Rong S, Anver M, Vande Woude GF.
    Oncogene; 1996 Aug 15; 13(4):853-6. PubMed ID: 8761307
    [Abstract] [Full Text] [Related]

  • 19. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
    Tiran Z, Oren A, Hermesh C, Rotman G, Levine Z, Amitai H, Handelsman T, Beiman M, Chen A, Landesman-Milo D, Dassa L, Peres Y, Koifman C, Glezer S, Vidal-Finkelstein R, Bahat K, Pergam T, Israel C, Horev J, Tsarfaty I, Ayalon-Soffer M.
    Clin Cancer Res; 2008 Jul 15; 14(14):4612-21. PubMed ID: 18628476
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.